5MFD image
Deposition Date 2016-11-18
Release Date 2017-07-19
Last Version Date 2024-01-17
Entry Detail
PDB ID:
5MFD
Keywords:
Title:
Designed armadillo repeat protein YIIIM''6AII in complex with pD_(KR)5
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.21
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 63
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:YIIIM''6AII
Chain IDs:A, C, E, G, I, J, K, L
Chain Length:328
Number of Molecules:8
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:Capsid decoration protein,pD_(KR)5
Gene (Uniprot):D
Chain IDs:B, D, F, H
Chain Length:109
Number of Molecules:4
Biological Source:Enterobacteria phage lambda
Ligand Molecules
Primary Citation
Structures of designed armadillo repeat proteins binding to peptides fused to globular domains.
Protein Sci. 26 1942 1952 (2017)
PMID: 28691351 DOI: 10.1002/pro.3229

Abstact

Designed armadillo repeat proteins (dArmRP) are α-helical solenoid repeat proteins with an extended peptide binding groove that were engineered to develop a generic modular technology for peptide recognition. In this context, the term "peptide" not only denotes a short unstructured chain of amino acids, but also an unstructured region of a protein, as they occur in termini, loops, or linkers between folded domains. Here we report two crystal structures of dArmRPs, in complex with peptides fused either to the N-terminus of Green Fluorescent Protein or to the C-terminus of a phage lambda protein D. These structures demonstrate that dArmRPs bind unfolded peptides in the intended conformation also when they constitute unstructured parts of folded proteins, which greatly expands possible applications of the dArmRP technology. Nonetheless, the structures do not fully reflect the binding behavior in solution, that is, some binding sites remain unoccupied in the crystal and even unexpected peptide residues appear to be bound. We show how these differences can be explained by restrictions of the crystal lattice or the composition of the crystallization solution. This illustrates that crystal structures have to be interpreted with caution when protein-peptide interactions are characterized, and should always be correlated with measurements in solution.

Legend

Protein

Chemical

Disease

Primary Citation of related structures